Trillium Therapeutics Inc. EBITDA 2014-2021 | TRIL

Trillium Therapeutics Inc. ebitda from 2014 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Trillium Therapeutics Inc. Annual EBITDA
(Millions of US $)
2020 $-61
2019 $-32
2018 $-34
2017 $-28
2016 $-22
2015 $-16
2014 $-11
2013 $-4
2012 $-1
Trillium Therapeutics Inc. Quarterly EBITDA
(Millions of US $)
2021-09-30 $-19
2021-06-30 $-19
2021-03-31 $-11
2020-12-31 $-8
2020-09-30 $-13
2020-06-30 $-24
2020-03-31 $-17
2019-12-31 $-9
2019-09-30 $-7
2019-06-30 $-8
2019-03-31 $-8
2018-12-31 $-8
2018-09-30 $-8
2018-06-30 $-10
2018-03-31 $-8
2017-12-31 $-8
2017-09-30 $-6
2017-06-30 $-6
2017-03-31 $-8
2016-12-31 $-7
2016-09-30 $-6
2016-06-30 $-5
2016-03-31 $-5
2015-12-31 $-4
2015-09-30 $-4
2015-06-30 $-5
2015-03-31 $-4
2014-12-31 $-4
2014-09-30 $-2
2014-06-30 $-3
2014-03-31 $-2
2013-12-31 $-1
2013-09-30 $-1
2013-06-30 $-1
2013-03-31 $-0